Avita Medical Stock Today
| RCEL Stock | USD 9.03 0.48 5.61% |
PerformanceVery Weak
| Odds Of DistressVery High
|
Avita Medical is selling for 9.03 as of the 17th of March 2025. This is a 5.61 percent increase since the beginning of the trading day. The stock's lowest day price was 8.54. Avita Medical has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 17th of December 2024 and ending today, the 17th of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 1st of October 2019 | Category Healthcare | Classification Health Care |
AVITA Medical, Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. AVITA Medical, Inc. was incorporated in 2000 and is based in Valencia, California. Avita Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. The company has 26.36 M outstanding shares of which 1.94 M shares are at this time shorted by private and institutional investors with about 9.21 trading days to cover. More on Avita Medical
Moving together with Avita Stock
| 0.67 | VANI | Vivani Medical Earnings Call This Week | PairCorr |
Moving against Avita Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Avita Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| President CEO | James Corbett | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsAvita Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Avita Medical's financial leverage. It provides some insight into what part of Avita Medical's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Avita Medical (RCEL) is traded on NASDAQ Exchange in USA. It is located in 28159 Avenue Stanford, Valencia, CA, United States, 91355 and employs 260 people. Avita Medical is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 225.36 M. Avita Medical conducts business under Biotechnology sector and is part of Health Care industry. The entity has 26.36 M outstanding shares of which 1.94 M shares are at this time shorted by private and institutional investors with about 9.21 trading days to cover.
Avita Medical currently holds about 84.17 M in cash with (48.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.67.
Check Avita Medical Probability Of Bankruptcy
Ownership AllocationAvita Medical holds a total of 26.36 Million outstanding shares. Almost 74.44 percent of Avita Medical outstanding shares are held by general public with 0.82 (percent) owned by insiders and only 24.74 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Avita Ownership Details
Avita Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Nuveen Asset Management, Llc | 2024-12-31 | 71.7 K | |
| Charles Schwab Investment Management Inc | 2024-12-31 | 70.9 K | |
| D. E. Shaw & Co Lp | 2024-12-31 | 66.5 K | |
| Bank Of New York Mellon Corp | 2024-12-31 | 53.2 K | |
| Jane Street Group Llc | 2024-12-31 | 53 K | |
| Jpmorgan Chase & Co | 2024-12-31 | 52.7 K | |
| Delta Investment Management, Llc | 2024-12-31 | 52.5 K | |
| Ameriprise Financial Inc | 2024-12-31 | 47.6 K | |
| Barclays Plc | 2024-12-31 | 41 K | |
| Blackrock Inc | 2024-12-31 | 1.9 M | |
| Vanguard Group Inc | 2024-12-31 | 1.4 M |
Avita Medical Historical Income Statement
Avita Stock Against Markets
Avita Medical Corporate Management
| Rob Hall | Senior Resources | Profile | |
| David Melbye | Senior Operations | Profile | |
| Michael MBA | Chief Officer | Profile | |
| Jessica Ekeberg | Investor Executive | Profile | |
| Robin VanDenburgh | Senior Sales | Profile | |
| David OToole | Chief Officer | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Avita Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avita Medical. If investors know Avita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avita Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.39) | Revenue Per Share | Quarterly Revenue Growth 0.297 | Return On Assets | Return On Equity |
The market value of Avita Medical is measured differently than its book value, which is the value of Avita that is recorded on the company's balance sheet. Investors also form their own opinion of Avita Medical's value that differs from its market value or its book value, called intrinsic value, which is Avita Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avita Medical's market value can be influenced by many factors that don't directly affect Avita Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avita Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Avita Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avita Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.